Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 7,480 |
|
|||||
| News | - | ||||||
| Day High | 2.0499 | Low High |
|||||
| Day Low | 2.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ProQR Therapeutics NV | PRQR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0499 | 2.50% | 2.0499 | 09:35:40 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.01 | 2.01 | 2.0499 | 2.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 26 | 7,480 | $ 2.04 | $ 15,246 | - | 1.11 - 3.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:37:39 | 1 | $ 2.035 | USD |
ProQR Therapeutics NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 162.71M | 81.35M | - | 6.59M | -28.12M | -0.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProQR Therapeutics NV News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRQR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.04 | 2.10 | 1.81 | 1.94 | 167,242 | 0.0099 | 0.49% |
| 1 Month | 2.37 | 2.49 | 1.81 | 2.12 | 150,148 | -0.3201 | -13.51% |
| 3 Months | 2.11 | 2.70 | 1.81 | 2.14 | 207,548 | -0.0601 | -2.85% |
| 6 Months | 1.30 | 3.29 | 1.11 | 2.04 | 260,489 | 0.7499 | 57.68% |
| 1 Year | 2.28 | 3.29 | 1.11 | 1.88 | 266,722 | -0.2301 | -10.09% |
| 3 Years | 6.23 | 9.09 | 0.53 | 2.83 | 815,347 | -4.18 | -67.10% |
| 5 Years | 11.24 | 13.28 | 0.53 | 4.53 | 746,108 | -9.19 | -81.76% |
ProQR Therapeutics NV Description
| ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. |
